Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.
Gottenberg JE, Ravaud P, Bardin T, Cacoub P, Cantagrel A, Combe B, Dougados M, Flipo RM, Godeau B, Guillevin L, Le Loët X, Hachulla E, Schaeverbeke T, Sibilia J, Baron G, Mariette X; AutoImmunity and Rituximab registry and French Society of Rheumatology. Gottenberg JE, et al. Among authors: le loet x. Arthritis Rheum. 2010 Sep;62(9):2625-32. doi: 10.1002/art.27555. Arthritis Rheum. 2010. PMID: 20506353 Free article.
CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.
Sellam J, Rouanet S, Hendel-Chavez H, Miceli-Richard C, Combe B, Sibilia J, Le Loët X, Tebib J, Jourdan R, Dougados M, Taoufik Y, Mariette X. Sellam J, et al. Among authors: le loet x. Arthritis Rheum. 2013 Sep;65(9):2253-61. doi: 10.1002/art.38023. Arthritis Rheum. 2013. PMID: 23740460 Free article. Clinical Trial.
Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice.
Frazier-Mironer A, Dougados M, Mariette X, Cantagrel A, Deschamps V, Flipo RM, Logeart I, Schaeverbeke T, Sibilia J, Le Loët X, Combe B. Frazier-Mironer A, et al. Among authors: le loet x. Joint Bone Spine. 2014 Jul;81(4):352-9. doi: 10.1016/j.jbspin.2014.02.014. Epub 2014 Apr 8. Joint Bone Spine. 2014. PMID: 24721422
Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry.
Couderc M, Gottenberg JE, Mariette X, Pereira B, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Soubrier M; Club Rhumatismes et Inflammations. Couderc M, et al. Among authors: le loet x. Rheumatology (Oxford). 2014 Oct;53(10):1788-93. doi: 10.1093/rheumatology/keu176. Epub 2014 May 11. Rheumatology (Oxford). 2014. PMID: 24821852
Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registry.
Payet S, Soubrier M, Perrodeau E, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Gottenberg JE, Mariette X. Payet S, et al. Among authors: le loet x. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1289-95. doi: 10.1002/acr.22314. Arthritis Care Res (Hoboken). 2014. PMID: 25299001 Free article.
Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registry.
Lahaye C, Soubrier M, Mulliez A, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Mariette X, Gottenberg JE; French Society of Rheumatology. Lahaye C, et al. Among authors: le loet x. Rheumatology (Oxford). 2016 May;55(5):874-82. doi: 10.1093/rheumatology/kev437. Epub 2016 Jan 27. Rheumatology (Oxford). 2016. PMID: 26822072
271 results